Although PMOS Awareness Month has ended, the conversation continues, with experts saying closing diagnostic and care gaps requires ongoing efforts.
Feature|Articles|May 15, 2026
5 Things to Pay Attention to During Women's Health Month
Author(s)Giuliana Grossi
Fact checked by: Christina Mattina
Women’s Health Month highlights major 2026 shifts in menopause care, brain health, abortion access, doula coverage, and wearable tech.
Advertisement
Advertisement
Women's health is experiencing a watershed moment in 2026. After decades of underinvestment and overlooked research gaps, the sector is seeing unprecedented clinical innovation and policy scrutiny. From how we treat menopause to how women access abortion care, the evidence landscape is shifting rapidly. Here are 5 critical trends that every health care stakeholder should be tracking.
Related to this article
Among people with HIV, lung cancer screening eligibility rose from 6% to 15% in 6 years, but uptake stayed under 30%.
CAR T-cell therapy must be treated as a complete "vein-to-vein" episode, with community practices needing to take control of cases for a period of time.
Panelists say drug price negotiation, Medicaid changes, prior authorization, and 340B reform strain community oncology.
The 2026 COA Payer Exchange and Innovation Summit began with a panel on AI and the ever-changing digital infrastructure in community oncology.
CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
CMS finalized the mandatory GLOBE Model, tying Part B drug rebates to international prices in areas covering 25% of beneficiaries from Jan. 1, 2027.
Advertisement
Advertisement